Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

A cancer diagnosis can feel like life is suddenly on a clock — but it doesn’t have to be. With the right strategy, many people are living longer, fuller lives even after diagnosis. While medical ...

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...

Life-extending prostate cancer drug to be made available to thousands more patients - Men with high-risk prostate cancer that ...

Scott Adams, the mind behind the workplace comic “Dilbert,” has died at 68 following a cancer battle, his family confirmed ...

Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today (Friday, 23 January). NICE has recommended talazoparib ...

Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.